Quantitative measurement of 219Rn radioactivity in exhaled breath from patients with bone metastasis of castration-resistant prostate cancer treated with 223RaCl2

Quantitative measurement of 219Rn radioactivity in exhaled breath from patients with bone metastasis of castration-resistant prostate cancer treated with 223RaCl2

Abstract Background The α-emitting radionuclide radium-223 (223Ra) is widely used for the treatment of bone metastasis in patients with castration-resistant prostate cancer. However, 223Ra decays into radon-219 (219Rn) which is a noble-gas isotope, and 219Rn may escape from patients treated with 223...

Full description

Bibliographic Details
Main Authors: Kazuhiro Ooe, Tadashi Watabe, Takashi Kamiya, Takashi Yoshimura, Makoto Hosono, Atsushi Shinohara, Jun Hatazawa
Format: Article
Language:English
Published: SpringerOpen 2019-07-01
Series:EJNMMI Physics
Subjects:
Radium-223
Radon-219
Breath of patients
Effective dose to caregivers
Online Access:http://link.springer.com/article/10.1186/s40658-019-0249-8

Internet

http://link.springer.com/article/10.1186/s40658-019-0249-8

Similar Items